Stay updated on Ruxolitinib for Eosinophilic Disorders Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib for Eosinophilic Disorders Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site revision identifier was updated from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:14:41.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A sitewide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:18:50.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision marker changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:12:30.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T22:15:05.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The Study Details page for NCT03801434 now returns a 403 error, blocking access to the trial information and standard navigation.
    Difference
    0.5%
    Check dated 2026-09-26T21:52:52.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, replacing the study details with an error page. The HTML shows a 403 page instead of the expected ClinicalTrials.gov content.
    Difference
    19%
    Check dated 2026-09-19T19:20:04.000Z thumbnail image

Stay in the know with updates to Ruxolitinib for Eosinophilic Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.